The Messenger: Moderna, the Vaccine, and the Business Gamble That Changed the World
- 10h 30m 9s
- Peter Loftus
- Gildan Media
- 2022
At the start of 2020, Moderna was a waning biotech unicorn, still years away from delivering its first product despite a decade of development of a potentially breakthrough innovation: using RNA to combat disease. Investors were getting antsy or, worse, skeptical.
